Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Q8, Q9, and Q10 Questions and Answers

Q8, Q9, and Q10 Questions and Answers

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

November 17, 2011

April 15, 2020

Center for Drug Evaluation and Research

143dddaa-3858-4f11-a750-8ff7806e5dcd

Related Documents

Q8, Q9, & Q10 Questions and Answers -- Appendix: Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider)

Guidance DocumentAugust 13, 2012Center for Drug Evaluation and Research
View Details →

Q8(R2) Pharmaceutical Development

Guidance DocumentNovember 20, 2009Center for Drug Evaluation and Research
View Details →

Q11 Development and Manufacture of Drug Substances

Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.